On ECHEMI
Home > Drugs > Entacapone Registered Holders
Entacapone structure

Entacapone structure

Entacapone

Entacapone is a specific, potent, peripherally acting catechol-O-methyltransferase (COMT) inhibitor with IC50 of 151 nM for PD treatment.IC50 Value: 151 nMTarget: COMTin vitro: Entacapone inhibits catechol-O-methyltransferase(COMT) with similar IC50 in different tissues including live, duodenum, kidney and lung, but entacapone is more active than tolcapone in those tissues. Entacapone (< 100 μM) is a potent inhibitor of α-syn and β-amyloid (Aβ) oligomerization and fibrillogenesis, and al

Find 38 Related Holders

HEC PHARM CO LTD
United States United States

API Registration Country

API Active
SUVEN PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
JUBILANT BIOSYS LTD
United States United States

API Registration Country

API Active
HETERO LABS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
PIRAMAL PHARMA LTD
United States United States

API Registration Country

API Active
COHANCE LIFESCIENCES LTD
United States United States

API Registration Country

API Active
  • Founded in:

    2005-09-28 00:00:00
  • Country:

    United States United States
MACLEODS PHARMACEUTICALS LTD
India India

API Registration Country

API Active
  • Founded in:

    1989-06-05 00:00:00
  • Country:

    India India
  • Address:

    304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) NA MUMBAI MH 400059 IN
  • Registered Funds:

    648.7 million INR
Fermion Oy
Finland Finland

API Registration Country

API Active
  • Founded in:

    2003-10-07 00:00:00
  • Country:

    Finland Finland
WOCKHARDT LTD
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    WOCKHARDT TOWERS, BANDRA KURLA COMPLEX, EXTERIOR - EX
  • Email:

Recommended Suppliers of Entacapone
View 64 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.